The efficacy and safety of taletrectinib in patients with TKI-naïve or crizotinib-pretreated ROS1-positive non–small cell lung cancer (NSCLC).Wěi Li, Caicun Zhou, Kunyan Li et al.|Journal of Clinical Oncology|2022Cited by 12
Abstract PS15-02: A Phase Ⅰb Study of D-0502 as Monotherapy for Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer: Results from the Dose-Expansion StageJiayu Wang, Binghe Xu, Tao Sun et al.|Cancer Research|2024Cited by 1